Charles River Laboratories International Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Charles River Laboratories International Inc 's ROA in the third quarter of 2026?
Charles River Laboratories International inc achieved a return on average assets (ROA) of 0.53 % in its third quarter of 2026, which is below Charles River Laboratories International Inc 's average return on assets, which stands at 3.77%.

ROA has improved compared to -3.1% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 240 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 26 2026 quarter, so far to 2814, from total ROA ranking in the second quarter of 2026 at 3199.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 26 2026) III. Quarter	(Jun 27 2026) II. Quarter	(Mar 28 2026) I. Quarter	(Dec 27 2025) IV. Quarter	(Sep 27 2025) III. Quarter
Y / Y Total Assets Change	4.98 %	2.7 %	5.37 %	-1.94 %	-6.16 %
Y / Y Net Income Change	499.52 %	-	-	-	-20.97 %
Net Income (TTM) in million	41	-236	-183	-142	-80
Return On Assets (TTM)	0.53 %	-3.1 %	-2.42 %	-1.9 %	-1.06 %
CRL's Total Ranking	# 2814	# 3199	# 2726	# 2718	# 2638
Total Assets (TTM) in million	7,850	7,719	7,940	7,342	7,478
Seq. Total Assets Change	1.7 %	-2.78 %	8.14 %	-1.81 %	-0.5 %
Seq. Net Income Change	-	-	-	-	5.43 %

CRL's 5 Years Annual ROA >> Back to CRL Management Effectiveness >> Compare CRL ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 15
Sector	# 241
Overall	# 2838

Return On Assets Statistics
High	Average	Low
7.73 %	3.77 %	-16 %
(Mar 26 2016)		(Jun 25 2011)

Financial Statements
Charles River Laboratories International Inc 's Assets	$ 7,850 million	CRL's Balance sheet
Charles River Laboratories International Inc 's Income	$ 333 million	Quarterly CRL's Income Statement
CRL's Income by Division		See CRL's Income by Division

Annual Return On Assets	(Dec 27 2025) FY 2025	(Dec 28 2024) FY 2024	(Dec 30 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 25 2021) FY 2021
Y / Y Total Assets Change	-1.94 %	-8.2 %	7.85 %	8.27 %	28.07 %
Total Assets in million	7,342	7,487	8,157	7,563	6,985
Y / Y Net Income Change	-	-94.74 %	-2.48 %	23.51 %	9.18 %
Net Income in million	-142	25	480	493	399
Annual Return On Assets	-1.94 %	0.34 %	5.89 %	6.51 %	5.71 %

CRL's 5 Years Annual ROA >> Back to CRL Management Effectiveness >> Compare CRL ROA to its Competitors

More Return On Assets Ratios
CRL's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CRL's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CRL's Competitors
Subscribers only: Roa for Charles River Laboratories International Inc 's Suppliers
Subscribers only: Return On Assets for CRL's Customers

You may also want to know
CRL's Roi	CRL's Inventory Turnover Ratio	CRL's Growth Rates	CRL's Dividend Comparisons
	CRL's Profitability Ratios	CRL's Asset Turnover Ratio	CRL's Dividend Growth
CRL's Roe	CRL's Valuation Ratios	CRL's Financial Strength Ratios	CRL's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 26 2026, within Healthcare Sector	ROA
Teva Pharmaceutical Industries Limited	1.26 %
Community Health Systems Inc	1.21 %
Biogen Inc	1.13 %
Integra Lifesciences Holdings Corp	0.37 %

Date modified: 2026-11-05T14:33:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.